Notch signaling in vascular endothelial cells, angiogenesis, and tumor progression: an update and prospective

A Akil, AK Gutiérrez-García, R Guenter… - Frontiers in cell and …, 2021 - frontiersin.org
The Notch signaling pathway plays an essential role in a wide variety of biological
processes including cell fate determination of vascular endothelial cells and the regulation …

[HTML][HTML] Signaling pathways in thyroid cancer and their therapeutic implications

S Jin, O Borkhuu, W Bao, YT Yang - Journal of clinical medicine …, 2016 - ncbi.nlm.nih.gov
Thyroid cancer is a common malignancy of endocrine system, and has now become the
fastest increasing cancer among all the malignancies. The development, progression …

Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth

XM Yu, R Jaskula-Sztul, K Ahmed, AD Harrison… - Molecular cancer …, 2013 - AACR
Anaplastic thyroid carcinoma (ATC) is an extremely aggressive malignancy with
undifferentiated features, for which conventional treatments, including radioactive iodine …

MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit

A Spitschak, C Meier, B Kowtharapu, D Engelmann… - Molecular cancer, 2017 - Springer
Background Dominant-activating mutations in the RET proto-oncogene, a receptor tyrosine
kinase, are responsible for the development of medullary thyroid carcinoma (MTC) and …

Notch signaling in thyroid cancer

R Guenter, Z Patel, H Chen - Notch Signaling in Embryology and Cancer …, 2021 - Springer
Thyroid cancer is the most common malignancy of the endocrine system with a steadily
rising incidence. The term “thyroid cancer” encompasses a spectrum of subtypes, namely …

Cancer stem-like cells and thyroid cancer

Z Guo, H Hardin, RV Lloyd - Endocrine-Related Cancer, 2014 - erc.bioscientifica.com
Thyroid cancer is one of the most rapidly increasing malignancies. The reasons for this
increase is not completely known, but increases in the diagnosis of papillary thyroid …

KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy

G Chen, R Jaskula–Sztul, A Harrison, A Dammalapati… - Biomaterials, 2016 - Elsevier
Neuroendocrine (NE) cancers can cause significant patient morbidity. Besides surgery,
there are no curative treatments for NE cancers and their metastases, emphasizing the need …

Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction

R Jaskula-Sztul, J Eide, S Tesfazghi… - Molecular cancer …, 2015 - AACR
Notch1-3 are transmembrane receptors that appear to be absent in medullary thyroid cancer
(MTC). Previous research has shown that induction of Notch1 has a tumor-suppressor effect …

Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches

PJ Harris, KC Bible - Expert opinion on investigational drugs, 2011 - Taylor & Francis
Introduction: Thyroid cancer is an emerging public health concern. In the USA, its incidence
has doubled in the past decade, making it the eighth most commonly diagnosed neoplasm …

Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo

TP Wyche, A Dammalapati, H Cho, AD Harrison… - Cancer gene …, 2014 - nature.com
Carcinoids are slow-growing neuroendocrine tumors (NETs) that are characterized by
hormone overproduction; surgery is currently the only option for treatment. Activation of the …